Advanced search

Instruments

Name		Stock exchange	Average volume	Price	Type
THOMAS WYATT NIGERIA PLC	THOMASWY	Nigerian S.E.	86,592	1.78 NGN	Stock
THOMAS COOK (INDIA) LIMITED	THOMASCOOK	Bombay S.E. +1 Other	73,060	211.6 INR	Stock
THOMAS COOK (INDIA) LIMITED	THOMASCOOK	NSE India S.E.	996,301	211.7 INR
THOMAS C 3.8/JUL23		Deutsche Boerse AG	-	- %	Bond
THOMAS C 3.8/JUL23		BOERSE MUENCHEN	-	- %	Bond
THOMAS PHARMACEUTICALS LTD	TPHM	OTC Markets	-	- USD	Stock

News (78)

Coterra Energy Evaluating Lot of Assets	05-03	CI
Coterra Energy to Participate at Upcoming Conference	23-08-30	BU
Renewables companies hit brakes on Alberta projects after govt delays approvals	23-08-21	RE
Coterra Energy Reports Second-Quarter 2023 Results, Announces Quarterly Dividend	23-08-07	BU
COTERRA ENERGY INC. : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders (form 8-K)	23-05-05	AQ
Coterra Energy Reports First-Quarter 2023 Results, Announces Quarterly Dividend and Provides Update on Share Repurchase Program	23-05-04	BU
Coterra Energy Reports Fourth-Quarter and Full-Year 2022 Results, Provides 2023 Outlook and Updates Shareholder Return Strategy	23-02-22	BU
Coterra Energy to Participate at Upcoming Conference	22-11-10	PR
COTERRA ENERGY INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	22-11-04	AQ
Transcript : Coterra Energy Inc., Q3 2022 Earnings Call, Nov 04, 2022	22-11-04
Coterra Energy Reports Third-Quarter 2022 Results, Announces Quarterly Dividend and Provides Update on Share Repurchase Program	22-11-03	PR
Coterra Energy Inc. Announces Executive Changes	22-11-02	CI
Brompton Oil Split : Proxy Voting Record (July 1, 2021 to June 30, 2022)	22-08-28	PU
Coterra Energy : Reports Second-Quarter 2022 Results, Announces Quarterly Dividend and Provides Update on Share Repurchase Program - Form 8-K	22-08-03	PU
Coterra Energy Reports Second-Quarter 2022 Results, Announces Quarterly Dividend and Provides Update on Share Repurchase Program	22-08-02	PR
COTERRA ENERGY INC. : Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	22-05-04	AQ
Coterra Energy Reports First-Quarter 2022 Results, Announces Quarterly Dividend and Provides Update on Share Repurchase Program	22-05-02	PR
Coterra Energy to Participate at Upcoming Conference	22-03-21	PR
Alignment Healthcare : Management Change/Compensation - Form 8-K/A	22-03-01	PU
ALIGNMENT HEALTHCARE, INC. Change in Directors or Principal Officers (form 8-K/A)	22-03-01	AQ
Coterra Energy : Reports Fourth-Quarter and Full-Year 2021 Results, Provides 2022 Outlook and Updates Shareholder Return Strategy - Form 8-K	22-02-24	PU
Coterra Energy Reports Fourth-Quarter and Full-Year 2021 Results, Provides 2022 Outlook and Updates Shareholder Return Strategy	22-02-23	PR
Coterra Energy to Present at Upcoming Conference	22-01-04	PR
Alignment Healthcare : Appoints Jody Bilney and Yon Yoon Jorden to its Board of Directors - Form 8-K	21-12-27	PU
Alignment Healthcare Appoints Jody Bilney and Yon Yoon Jorden to its Board of Directors	21-12-27	AQ
COTERRA ENERGY INC. : Change in Directors or Principal Officers (form 8-K)	21-12-16	AQ
Coterra Energy to Present at Upcoming Conference	21-11-15	PR
Coterra Energy Reports Third-Quarter 2021 Results and Accelerates Variable Dividend	21-11-03	PR
Cabot Oil & Gas : Coterra Announces Special Dividend	21-10-04	PR
Cimarex Energy : Amended And Restated Credit Agreement (Form 8-K)	21-10-01	PU
CIMAREX ENERGY CO : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits (form 8-K)	21-10-01	AQ
Cimarex Energy Co. Announces Board Changes	21-10-01	CI
Cabot Oil & Gas : Newly Created Energy Company Benefits from Strong Financial Foundation and Premier, Diverse Assets (Form 8-K)	21-10-01	PU
COTERRA ENERGY INC. : Completion of Acquisition or Disposition of Assets, Material Modification to Rights of Security Holders, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	21-10-01	AQ
Cabot Oil & Gas : and Cimarex Energy Complete Combination, Forming Coterra Energy	21-10-01	PR
Coterra Energy Inc. Announces Management Appointments	21-10-01	CI
Cabot Oil & Gas Corporation) completed the acquisition of Cimarex Energy Co. in a merger of equals transaction.	21-09-30	CI
Cabot Oil & Gas : and Cimarex Energy Shareholders Approve Merger	21-09-29	PR
CIMAREX ENERGY CO : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)	21-09-08	AQ
CABOT OIL & GAS CORP : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)	21-09-08	AQ
Cimarex Energy : Treatment of your Golden Equity Awards (Form 8-K)	21-06-30	PU
CIMAREX ENERGY CO : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	21-06-30	AQ
CABOT OIL & GAS CORP : Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)	21-05-24	AQ
Cimarex Energy : Creating a Premier, Diversified Energy Company with a Strong Free Cash Flow Profile; Positioned to Deliver Superior and Sustainable Returns (Form 8-K)	21-05-24	PU
CIMAREX ENERGY CO : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)	21-05-24	AQ

12NextSee all

Companies (50)

CHRISTIAN DIOR SE 146 B $

Christian Dior SE is a holding company organized around 6 areas of activity: - sale of fashion products and leather goods (48.9% of net sales): primarily Louis Vuitton, Fendi, Céline, Loewe, Givenchy, Kenzo, Thomas Pink, Berluti, Pucci and Loro Piana bra ...

CHRISTIAN DIOR SE 146 B $

DAIMLER TRUCK HOLDING AG 35 896 M $

Daimler Truck Holding AG is specialized in designing, manufacturing and marketing trucks and buses. The business activity is structured around 4 areas: - medium and heavy truck sales: Mercedes-Benz, Fuso, Freightliner, Western Star and BharatBenz brands; ...

DAIMLER TRUCK HOLDING AG 35 896 M $

INGERSOLL RAND INC. 37 434 M $

Ingersoll Rand Inc. specializes in the design, manufacture and marketing of industrial technological equipment. The group provides compressed air equipment (screw compressors, reciprocating compressors, centrifugal compressors, air dryers, air filters, et ...

GRUPO BIMBO, S.A.B. DE C.V. 18 284 M $

Grupo Bimbo SAB de CV is a Mexico-based company engaged in the food processing sector. The Company focuses on the manufacture, distribution and sale of bread, breakfast bread muffins and bagels, frozen bread, cakes and smaller cakes, sweet and non-sweet c ...

GRUPO BIMBO, S.A.B. DE C.V. 18 284 M $

FAIRFAX FINANCIAL HOLDINGS LIMITED 25 740 M $

Fairfax Financial Holdings Limited is a Canada-based holding company. The Company, through its subsidiaries, is engaged in property and casualty insurance and reinsurance and the associated investment management. The Companyâs segments include Property ...

FAIRFAX FINANCIAL HOLDINGS LIMITED 25 740 M $

1234Next

Insiders

Thomas Jorden

Currently, Thomas E. Jorden is Chairman, President & Chief Executive Officer for Cimarex Energy Co. and Chairman for American Exploration & Production Council. Mr. Jorden is also Chairman-Trustees Board at Colorado School of Mines. In his past career Mr. Jorden held the position of Vice President-Exploration for Key Production Co., Inc. and Principal at Union Pacific Resources, Inc. Mr. Jorden received a graduate degree and an undergraduate degree from Colorado School of Mines.

David Emerson Jorden's current job(s) include being the CEO, CFO, Secretary & Director at Nuo Therapeutics, Inc. since 2016, and the Chief Executive Officer & Director at Nanospectra Biosciences, Inc. since 2013.
Mr. Jorden's former job(s) include being the Chief Financial Officer & Director at PLx Pharma, Inc., a Director at Opexa Therapeutics, Inc. from 2008 to 2013, a Vice President at Morgan Stanley from 2003 to 2008, a Principal at Fayez Sarofim & Co., and the Chief Financial Officer & Vice President at Genometrix, Inc. from 2000 to 2002.
Additionally, he served as the Chief Financial Officer at PLx Pharma, Inc. from 2015 to 2017.
Mr. Jorden's education history includes an undergraduate degree from The University of Texas at Austin in 1984 and an MBA from Kellogg School of Management.

Jorden Wood

John Jorden

No results for this search